USANA HEALTH SCIENCES INC
USNA evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for USNA—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$348.6M
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Apr 4, 2026.
Run USANA HEALTH SCIENCES INC through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available USANA HEALTH SCIENCES INC facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
D/E 0.27
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
0 buys · 7 sells (180d)
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
137
Total value held
$171.3M
| Holder | Shares | Value |
|---|---|---|
| blackrock, inc. | 1,190,416 | $20.8M |
| pzena investment management llc | 1,108,933 | $19.4M |
| renaissance technologies llc | 1,017,630 | $17.8M |
| vanguard capital management llc | 958,086 | $16.7M |
| dimensional fund advisors lp | 834,223 | $14.6M |
| vanguard portfolio management llc | 338,274 | $5.9M |
| charles schwab investment management inc | 333,112 | $5.8M |
| aqr capital management llc | 296,420 | $5.2M |
| geode capital management, llc | 264,434 | $4.6M |
| state street corp | 248,035 | $4.3M |
Showing top 10 of 137 institutional holders of USANA HEALTH SCIENCES INC. Open the full 13F history after sign-in.
Short Interest
as of May 22, 2026- % of float
- 4.6%
- Days to cover
- 5.1
- Shares short
- 501,916
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
USNA short interestGovernance
Frequently asked questions
Who is the CEO of USANA HEALTH SCIENCES INC?
Mr. Kevin G. Guest is the chief executive officer of USANA HEALTH SCIENCES INC (USNA).
Where is USANA HEALTH SCIENCES INC headquartered?
USANA HEALTH SCIENCES INC (USNA) is headquartered in Salt Lake City, UT, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.